Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × sapanisertib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Advanced Nonhematologic Malignancies 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Neoplasms 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Dermatofibrosarcoma 1 Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 149 Fluorouracil 45 Capecitabine 45 Oxaliplatin 42 130-nm albumin-bound paclitaxel 42 Albumin-Bound Paclitaxel 38 Leucovorin 31 Erlotinib Hydrochloride 30 pembrolizumab 22 Radiotherapy 22 Irinotecan 21 Radiosurgery 19 Bevacizumab 19 Docetaxel 17 Cyclophosphamide 16 Cetuximab 13 folfirinox 12 Taxes 12 Cisplatin 11 Nivolumab 10 Surgical Procedures, Operative 7 Paclitaxel 7 Ipilimumab 7 dehydroftorafur 6 Standard of Care 6 Radiation 6 spartalizumab 5 ruxolitinib 5 durvalumab 5 avelumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡